Development of an immunoenzymatic assay using a monoclonal antibody against a 50-kDa catabolite from the P126 Plasmodium falciparum protein to the diagnosis of malaria infection

The WHO criterion of defering any donation of blood by a confirmed case of malaria for three years after cessation of therapy can not be applied in areas where malaria in endemic. For this reason we developed an immunoenzymatic assay for the detection of plasmodial antigens for blood screening in ma...

Full description

Bibliographic Details
Main Authors: Maria de Fátima Ferreira da Cruz, Roberto Machado Passo, Bernard Fortier, Cláudio Daniel Ribeiro
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 1992-01-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000700031
_version_ 1797756671361024000
author Maria de Fátima Ferreira da Cruz
Roberto Machado Passo
Bernard Fortier
Cláudio Daniel Ribeiro
author_facet Maria de Fátima Ferreira da Cruz
Roberto Machado Passo
Bernard Fortier
Cláudio Daniel Ribeiro
author_sort Maria de Fátima Ferreira da Cruz
collection DOAJ
description The WHO criterion of defering any donation of blood by a confirmed case of malaria for three years after cessation of therapy can not be applied in areas where malaria in endemic. For this reason we developed an immunoenzymatic assay for the detection of plasmodial antigens for blood screening in malararial endemic areas. So, we tested sera from 191 individuals. Among patients with active disease 100% of the cases of Plasmodium falciparum or mixed infections and 91.7% of those with P. vivax were positive for the presence of plasmodial antigens. The lower parasitaemia detected was 0.0003% for P. vivax malária. When the frequency of positive circulating malarial antigens was evaluated among asymptomatic and symptomatic individuals with negative TBS, positive results were found in respectively 38.7% and 17.7% of the individuals studied in the 30 days after confirmed malaria attack. Data provide by these assays have shown that ELISA seemed to be more sensitive than parasitological examination for malaria diagnosis. This test by virtue of its high sensivity and the facilities in processing a large number of specimens, can prove to be useful in endemic areas for the recognition of asymptomatic malaria and screening of blood donors.
first_indexed 2024-03-12T18:04:53Z
format Article
id doaj.art-da0fc6fc06eb4fbd83a35b7e4f31778c
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T18:04:53Z
publishDate 1992-01-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-da0fc6fc06eb4fbd83a35b7e4f31778c2023-08-02T09:32:16ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80601992-01-018718719210.1590/S0074-02761992000700031Development of an immunoenzymatic assay using a monoclonal antibody against a 50-kDa catabolite from the P126 Plasmodium falciparum protein to the diagnosis of malaria infectionMaria de Fátima Ferreira da CruzRoberto Machado PassoBernard FortierCláudio Daniel RibeiroThe WHO criterion of defering any donation of blood by a confirmed case of malaria for three years after cessation of therapy can not be applied in areas where malaria in endemic. For this reason we developed an immunoenzymatic assay for the detection of plasmodial antigens for blood screening in malararial endemic areas. So, we tested sera from 191 individuals. Among patients with active disease 100% of the cases of Plasmodium falciparum or mixed infections and 91.7% of those with P. vivax were positive for the presence of plasmodial antigens. The lower parasitaemia detected was 0.0003% for P. vivax malária. When the frequency of positive circulating malarial antigens was evaluated among asymptomatic and symptomatic individuals with negative TBS, positive results were found in respectively 38.7% and 17.7% of the individuals studied in the 30 days after confirmed malaria attack. Data provide by these assays have shown that ELISA seemed to be more sensitive than parasitological examination for malaria diagnosis. This test by virtue of its high sensivity and the facilities in processing a large number of specimens, can prove to be useful in endemic areas for the recognition of asymptomatic malaria and screening of blood donors.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000700031Plasmodium falciparumPlasmodium vivaxdiagnosisplasmodial antigenmonoclonalantibodyimmunoenzymatic assay
spellingShingle Maria de Fátima Ferreira da Cruz
Roberto Machado Passo
Bernard Fortier
Cláudio Daniel Ribeiro
Development of an immunoenzymatic assay using a monoclonal antibody against a 50-kDa catabolite from the P126 Plasmodium falciparum protein to the diagnosis of malaria infection
Memorias do Instituto Oswaldo Cruz
Plasmodium falciparum
Plasmodium vivax
diagnosis
plasmodial antigen
monoclonal
antibody
immunoenzymatic assay
title Development of an immunoenzymatic assay using a monoclonal antibody against a 50-kDa catabolite from the P126 Plasmodium falciparum protein to the diagnosis of malaria infection
title_full Development of an immunoenzymatic assay using a monoclonal antibody against a 50-kDa catabolite from the P126 Plasmodium falciparum protein to the diagnosis of malaria infection
title_fullStr Development of an immunoenzymatic assay using a monoclonal antibody against a 50-kDa catabolite from the P126 Plasmodium falciparum protein to the diagnosis of malaria infection
title_full_unstemmed Development of an immunoenzymatic assay using a monoclonal antibody against a 50-kDa catabolite from the P126 Plasmodium falciparum protein to the diagnosis of malaria infection
title_short Development of an immunoenzymatic assay using a monoclonal antibody against a 50-kDa catabolite from the P126 Plasmodium falciparum protein to the diagnosis of malaria infection
title_sort development of an immunoenzymatic assay using a monoclonal antibody against a 50 kda catabolite from the p126 plasmodium falciparum protein to the diagnosis of malaria infection
topic Plasmodium falciparum
Plasmodium vivax
diagnosis
plasmodial antigen
monoclonal
antibody
immunoenzymatic assay
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000700031
work_keys_str_mv AT mariadefatimaferreiradacruz developmentofanimmunoenzymaticassayusingamonoclonalantibodyagainsta50kdacatabolitefromthep126plasmodiumfalciparumproteintothediagnosisofmalariainfection
AT robertomachadopasso developmentofanimmunoenzymaticassayusingamonoclonalantibodyagainsta50kdacatabolitefromthep126plasmodiumfalciparumproteintothediagnosisofmalariainfection
AT bernardfortier developmentofanimmunoenzymaticassayusingamonoclonalantibodyagainsta50kdacatabolitefromthep126plasmodiumfalciparumproteintothediagnosisofmalariainfection
AT claudiodanielribeiro developmentofanimmunoenzymaticassayusingamonoclonalantibodyagainsta50kdacatabolitefromthep126plasmodiumfalciparumproteintothediagnosisofmalariainfection